genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Antibiotic Resistance Mechanism Shows Achilles’ Heel
Financing
Benchtop Genome Engineering Platform Developer Inscripta Raises $125M in Series D…
News
Human Genes 10% More Numerous, If You Count smORFs
News
Merck & Co., Sanofi Shell Out $5.2B in Deals to Strengthen…
Extracellular Matrix
Mapping Single-Cell pH Levels Could Hold Key to Improved Cancer Treatments
Insights
Insights
Insect Pupae May Transform Protein Production
Insights
Optimizing Biotherapeutic Onboarding
Insights
CRISPR Vehicles Break Down Barriers to In Vivo Genome Editing
Insights
For Whom the Perturbed Cell Signaling Pathway Tolls
Insights
Metabolomics Technology Navigates Oceans of Data
A-Lists
Cancer
Top 10 Immuno-Oncology Startups of 2019
Drug Discovery
Top 10 Pharma Companies of 2019
December 2019 Vol. 39 No. 12
Top 25 Biotech Companies of 2019
Insights
Top 10 Asia Biopharma Clusters 2019
Insights
Top 10 European Biopharma Clusters
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Antibiotic Resistance Mechanism Shows Achilles’ Heel
Financing
Benchtop Genome Engineering Platform Developer Inscripta Raises $125M in Series D…
News
Human Genes 10% More Numerous, If You Count smORFs
News
Merck & Co., Sanofi Shell Out $5.2B in Deals to Strengthen…
Magazine
All
Supplement
Insights
CRISPR Vehicles Break Down Barriers to In Vivo Genome Editing
Insights
For Whom the Perturbed Cell Signaling Pathway Tolls
Insights
Metabolomics Technology Navigates Oceans of Data
Insights
Taking Cell Lines to the Bank
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Upcoming Webinars
The Dynamic Microbiome
December 2019 Vol. 39 No. 12
Understanding and Overcoming the Immune Response from Synthetic mRNAs
December 2019 Vol. 39 No. 12
Accelerating AAV to the Clinic with Purification Improvements
December 2019 Vol. 39 No. 12
Evaluation of a Small-Scale Perfusion Mimic for Intensified Processes
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Insights
Insights
Featured posts
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Insights
Forces Unite to Move Molecular Dx Out of the Gates
Insights
Genome Editing Heads to Primetime
Insights
One-Stop-Shop Genome Editing Product Launched by Inscripta
Insights
Going Viral: The Next Generation of AAV Vectors
Insights
Genetics of Same-Sex Behavior Revealed
Insights
DNA Sequencing Accuracy Comes a Long Way
Insights
Eagle Genomics Soars into the Big Apple
Insights
Ginkgo Bioworks Co-Founder Honored with Rosalind Franklin Award
Insights
Gut Microbiome May Alter ALS Progression in Mice
Insights
MS Looks to Transcriptomics for Answers on Neuronal Vulnerability
Insights
CRISPR and LASER ART Eliminate HIV from Mice
Insights
Huntington’s Disease Therapy Uses the Power of Repression
Insights
Single Cell Writing May Unlock CRISPR’s Full Potential
Insights
Turning Drug Delivery Inside Out
Insights
Type 1 Diabetes Risk Lower in Infants with Rotavirus Vaccination
1
2
3
...
10
Page 1 of 10
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![Firm had previously rejected Astellas’ unsolicited bid of roughly $3.5 billion. [© Yuri Arcurs - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/May17_2010_495175_HandshakeBirdsEyeView_AstellasBuysOSI7721122207-2.jpg "Forces Unite to Move Molecular Dx Out of the Gates")
